---
title: "Splash Beverage finalizes joint venture with cannabinoid pharma group for CannEpil veterinary program"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294208182.md"
description: "Splash Beverage Group is finalizing a joint venture with an established cannabinoid pharmaceutical company to lead the CannEpil veterinary drug development program. This expands Splash's exclusive global license into veterinary therapeutics, targeting companion-animal oncology and chronic pain management, starting with canine indications. The partner will provide regulatory expertise, while Splash pays Argent BioPharma a 10% royalty on net revenues from veterinary applications."
datetime: "2026-07-29T12:31:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294208182.md)
  - [en](https://longbridge.com/en/news/294208182.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294208182.md)
---

# Splash Beverage finalizes joint venture with cannabinoid pharma group for CannEpil veterinary program

-   Splash Beverage Group is finalizing a joint venture with an established cannabinoid pharmaceutical company to lead CannEpil’s veterinary drug development program. \* The move follows an expansion of Splash’s exclusive global CannEpil license into veterinary therapeutics, adding a second FDA-regulated development platform. \* Initial veterinary focus targets companion-animal oncology, chronic pain management, with canine indications first. \* Splash expects the partner to bring executives with experience advancing cannabinoid medicines through regulatory approval, with more details to be announced soon. \* Splash will pay Argent BioPharma a 10% royalty on net revenues from veterinary CannEpil applications. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Splash Beverage Group Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607290830PRIMZONEFULLFEED9800159) on July 29, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [SBEV.US](https://longbridge.com/en/quote/SBEV.US.md)
- [SBEV+.US](https://longbridge.com/en/quote/SBEV+.US.md)
- [SBEVW.US](https://longbridge.com/en/quote/SBEVW.US.md)

## Related News & Research

- [Splash Beverage expands CannEpil license to veterinary therapeutics in 8-K amendment](https://longbridge.com/en/news/294409288.md)
- [Splash Beverage partners with Lupvindol to develop CannEpil-based veterinary drug for FDA conditional approval](https://longbridge.com/en/news/294876244.md)
- [PetVivo to exhibit at 2026 Fetch Kansas City Veterinary Conference](https://longbridge.com/en/news/296256800.md)
- [Earth Science Tech, Inc. (ETST) Acquires Zoolzy LLC to Drive Margin Expansion and Strategic Entry into the Veterinary Market | ETST Stock News](https://longbridge.com/en/news/296357540.md)
- [PetVivo, a Leading Provider of Veterinary Biomedicals, Reports Results for Fiscal Q1 2027 | PETV Stock News](https://longbridge.com/en/news/295975804.md)